Počet záznamů: 1  

Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation

  1. 1.
    SYSNO ASEP0519332
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevMicrobiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation
    Tvůrce(i) Procházková, Petra (MBU-M) RID, ORCID
    Roubalová, Radka (MBU-M) RID, ORCID
    Dvořák, Jiří (MBU-M) RID, ORCID
    Tlaskalová-Hogenová, Helena (MBU-M) RID, ORCID
    Čermáková, Martina (MBU-M) ORCID
    Tomášová, Petra (MBU-M)
    Šedivá, Blanka (MBU-M) ORCID
    Kuzma, Marek (MBU-M) ORCID, RID
    Bulant, J. (CZ)
    Bilej, Martin (MBU-M) RID, ORCID
    Hrabák, P. (CZ)
    Meisnerová, E. (CZ)
    Lambertová, A. (CZ)
    Papežová, H. (CZ)
    Číslo článku338
    Zdroj.dok.Microorganisms. - : MDPI
    Roč. 7, č. 9 (2019)
    Poč.str.15 s.
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovamicrobiome ; microbial metabolites ; fecal microbiota transplantation (FMT)
    Vědní obor RIVEE - Mikrobiologie, virologie
    Obor OECDMicrobiology
    CEPNV17-28905A GA MZd - Ministerstvo zdravotnictví
    Způsob publikováníOpen access
    Institucionální podporaMBU-M - RVO:61388971
    UT WOS000489131300065
    EID SCOPUS85074338940
    DOI10.3390/microorganisms7090338
    AnotaceThe change in the gut microbiome and microbial metabolites in a patient suffering from severe and enduring anorexia nervosa (AN) and diagnosed with small intestinal bacterial overgrowth syndrome (SIBO) was investigated. Microbial gut dysbiosis is associated with both AN and SIBO, and therefore gut microbiome changes by serial fecal microbiota transplantation (FMT) is a possible therapeutic modality. This study assessed the effects of FMT on gut barrier function, microbiota composition, and the levels of bacterial metabolic products. The patient treatment with FMT led to the improvement of gut barrier function, which was altered prior to FMT. Very low bacterial alpha diversity, a lack of beneficial bacteria, together with a great abundance of fungal species were observed in the patient stool sample before FMT. After FMT, both bacterial species richness and gut microbiome evenness increased in the patient, while the fungal alpha diversity decreased. The total short-chain fatty acids (SCFAs) levels (molecules presenting an important source of energy for epithelial gut cells) gradually increased after FMT. Contrarily, one of the most abundant intestinal neurotransmitters, serotonin, tended to decrease throughout the observation period. Overall, gut microbial dysbiosis improvement after FMT was considered. However, there were no signs of patient clinical improvement. The need for an in-depth analysis of the donor's stool and correct selection pre-FMT is evident.
    PracovištěMikrobiologický ústav
    KontaktEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Rok sběru2020
    Elektronická adresahttps://www.mdpi.com/2076-2607/7/9/338
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.